These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2. Wilkes BC; Schiller PW Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733 [TBL] [Abstract][Full Text] [Related]
24. Preparation and binding properties of radioiodinated analogues of dermorphin and deltorphin with high specificity for the mu- and delta-opioid receptors. Gaudriault G; Zsürger N; Vincent JP J Neurochem; 1997 Feb; 68(2):813-9. PubMed ID: 9003073 [TBL] [Abstract][Full Text] [Related]
25. The impact of β-azido(or 1-piperidinyl)methylamino acids in position 2 or 3 on biological activity and conformation of dermorphin analogues. Maciejczyk M; Lasota A; Frączak O; Kosson P; Misicka A; Nowakowski M; Ejchart A; Olma A J Pept Sci; 2016 Aug; 22(8):545-51. PubMed ID: 27443980 [TBL] [Abstract][Full Text] [Related]
26. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding. Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727 [TBL] [Abstract][Full Text] [Related]
27. Molecular determinants of receptor affinity and selectivity of the natural delta-opioid agonist, dermenkephalin. Sagan S; Amiche M; Delfour A; Mor A; Camus A; Nicolas P J Biol Chem; 1989 Oct; 264(29):17100-6. PubMed ID: 2551895 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and pharmacology of halogenated δ-opioid-selective [d-Ala(2)]deltorphin II peptide analogues. Pescatore R; Marrone GF; Sedberry S; Vinton D; Finkelstein N; Katlowitz YE; Pasternak GW; Wilson KR; Majumdar S ACS Chem Neurosci; 2015 Jun; 6(6):905-10. PubMed ID: 25844930 [TBL] [Abstract][Full Text] [Related]
29. 14-membered cyclic opioids related to dermorphin and their partially retro-inverso modified analogues. II. Preferred conformations in solution as studied by 1H-NMR spectroscopy. Yamazaki T; Mierke DF; Said-Nejad OE; Felder ER; Goodman M Int J Pept Protein Res; 1992 Feb; 39(2):161-81. PubMed ID: 1517015 [TBL] [Abstract][Full Text] [Related]
30. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists. Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552 [TBL] [Abstract][Full Text] [Related]
31. New insights on mu/delta selectivity of opioid peptides: conformational analysis of deltorphin analogues. Tancredi T; Temussi PA; Picone D; Amodeo P; Tomatis R; Salvadori S; Marastoni M; Santagada V; Balboni G Biopolymers; 1991 May; 31(6):751-60. PubMed ID: 1932571 [TBL] [Abstract][Full Text] [Related]
32. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13). Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and pharmacological activity of the N-terminal dermorphin tetrapeptide analogs with CH2-NH peptide bond isosteres. Salvadori S; Guerrini R; Borea PA; Tomatis R Int J Pept Protein Res; 1992 Nov; 40(5):437-44. PubMed ID: 1362392 [TBL] [Abstract][Full Text] [Related]
34. Highly potent side chain-main chain cyclized dermorphin-deltorphin analogues: an integrated approach including synthesis, bioassays, NMR spectroscopy and molecular modelling. Ro S; Zhu Q; Lee CW; Goodman M; Darlak K; Spatola AF; Chung NN; Schiller PW; Malmberg AB; Yaksh TL J Pept Sci; 1995; 1(3):157-74. PubMed ID: 9222993 [TBL] [Abstract][Full Text] [Related]
35. Structural modifications of the N-terminal tetrapeptide segment of [D-Ala2]deltorphin I: effects on opioid receptor affinities and activities in vitro and on antinociceptive potency. Schmidt R; Menard D; Mrestani-Klaus C; Chung NN; Lemieux C; Schiller PW Peptides; 1997; 18(10):1615-21. PubMed ID: 9437724 [TBL] [Abstract][Full Text] [Related]
36. Design of opioid peptides for a potential delta-receptor affinity label function: comparison with the mu-specific Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone. Rónai AZ; Hepp J; Magyar A; Borsodi A; Medzihradszky K Pharmacology; 1994 Aug; 49(2):121-31. PubMed ID: 7972321 [TBL] [Abstract][Full Text] [Related]
37. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity. Horan PJ; Wild KD; Misicka A; Lipkowski A; Haaseth RC; Hruby VJ; Weber SJ; Davis TP; Yamamura HI; Porreca F J Pharmacol Exp Ther; 1993 May; 265(2):896-902. PubMed ID: 8388462 [TBL] [Abstract][Full Text] [Related]
38. Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations. Loew G; Hashimoto G; Williamson L; Burt S; Anderson W Mol Pharmacol; 1982 Nov; 22(3):667-77. PubMed ID: 7155126 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and opioid activity of tyrosine sulfate containing dermorphin and deltorphin peptides. Marastoni M; Salvadori S; Balboni G; Scaranari V; Borea PA; Tomatis A Arzneimittelforschung; 1995 Feb; 45(2):116-9. PubMed ID: 7710429 [TBL] [Abstract][Full Text] [Related]
40. Helix-inducing alpha-aminoisobutyric acid in opioid mimetic deltorphin C analogues. Bryant SD; Guerrini R; Salvadori S; Bianchi C; Tomatis R; Attila M; Lazarus LH J Med Chem; 1997 Aug; 40(16):2579-87. PubMed ID: 9258365 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]